Clinical Considerations and Who Should Evaluate Each Option Both Calibrate and Found conduct medical screening to assess candidacy, including BMI thresholds, cardiovascular history, and medication interactions
timing considerations apply for women depending on menstrual status), oestradiol, LH, FSH Thyroid function: TSH and free T4 if TSH is abnormal General health markers based on clinical indication: full blood count, ferritin, vitamin D (if at risk of deficiency), HbA1c (if cardiovascular or diabetes risk factors present) Depending on findings, referral to specialist services may be appropriate, including endocrinology for hormonal disorders, gynaecology for menstrual disturbances, or psychology services for eating disorders or relationship counselling
A significantly reduced appetite is a new feeling, and many patients forget to nourish themselves properly
The incidence of these common adverse reactions was lower in the surveillance program than in the controlled clinical studies: Among the less frequent adverse reactions, there was no appreciable difference in incidence in controlled clinical studies or in the surveillance program
In comparative studies involving T2D subjects, the administration of injective semaglutide at a dosage of 1 mg once weekly was related to a mean weight reduction of 6.5 kg, while once-daily oral semaglutide determined a mean weight reduction of 4.5 kg (Figure 1B) [1, 7]
.jpg)
